Who owns ABIOMED?

Key details on ABIOMED (Ticker: ABMD)

Who owns ABIOMED?

Is ABMD a good stock to own? Find out who bought ABIOMED, who sold ABIOMED (ABMD) stock, and who holds a large position in ABIOMED.

Fund Name Number of Shares Share Valuation As Of
PRIMECAP Management Company 5.67M $372.56M June 30, 2015
Vanguard 3.20M $210.20M June 30, 2015
Palo Alto Investors 2.74M $180.25M June 30, 2015
BlackRock Fund Advisors 2.37M $156.08M June 30, 2015
Essex Woodlands Health Ventures 2.15M $141.32M June 30, 2015
Jackson Square Partners 1.83M $120.22M June 30, 2015
Tiger Global Management 1.69M $41.96M Sept. 30, 2014
Blue Mountain Capital Management 1.61M $41.87M March 31, 2014
Wellington Management Company 1.31M $93.87M March 31, 2015
Macquarie 1.20M $79.04M June 30, 2015
Millennium Management 1.14M $28.31M Sept. 30, 2014
William Blair $ Company 1.10M $72.28M June 30, 2015
Cortina Asset Management 1.06M $26.43M Sept. 30, 2014
Next Century Growth Investors 1.03M $39.21M Dec. 31, 2014
Royal Bank of Canada 1.00M $24.91M Sept. 30, 2014
BlackRock Institutional Trust Company, N.A. 970826 $63.81M June 30, 2015

Who sold ABIOMED?

Fund Name Date Sold Number of Shares Sold Share Valuation
Norges Bank Investment Management March 31, 2011 1.17M $17.02M
Portolan Capital Management March 31, 2011 1.10M $15.92M